Ait-Khaled M - Search Results

1

The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study Team.

Katlama C, Clotet B, Plettenberg A, Jost J, Arasteh K, Bernasconi E, Jeantils V, Cutrell A, Stone C, Ait-Khaled M, Purdon S. Katlama C, et al. AIDS. 2000 May 5;14(7):781-9. doi: 10.1097/00002030-200005050-00003. AIDS. 2000. PMID: 10839585 Clinical Trial.

2

HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy.

Miller V, Ait-Khaled M, Stone C, Griffin P, Mesogiti D, Cutrell A, Harrigan R, Staszewski S, Katlama C, Pearce G, Tisdale M. Miller V, et al. AIDS. 2000 Jan 28;14(2):163-71. doi: 10.1097/00002030-200001280-00012. AIDS. 2000. PMID: 10708287 Clinical Trial.

3

HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients.

Falloon J, Ait-Khaled M, Thomas DA, Brosgart CL, Eron JJ Jr, Feinberg J, Flanigan TP, Hammer SM, Kraus PW, Murphy R, Torres R, Masur H; CNA2007 Study Team. Falloon J, et al. AIDS. 2002 Feb 15;16(3):387-96. doi: 10.1097/00002030-200202150-00010. AIDS. 2002. PMID: 11834950 Clinical Trial.

4

Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy.

Ait-Khaled M, Rakik A, Griffin P, Cutrell A, Fischl MA, Clumeck N, Greenberg SB, Rubio R, Peters BS, Pulido F, Gould J, Pearce G, Spreen W, Tisdale M, Lafon S; CNA3003 International Study Team. Ait-Khaled M, et al. Antivir Ther. 2002 Mar;7(1):43-51. Antivir Ther. 2002. PMID: 12008787 Clinical Trial.

5

M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine.

Ait-Khaled M, Stone C, Amphlett G, Clotet B, Staszewski S, Katlama C, Tisdale M; CNA3002 International Study Team. Ait-Khaled M, et al. AIDS. 2002 Aug 16;16(12):1686-9. doi: 10.1097/00002030-200208160-00017. AIDS. 2002. PMID: 12172093

6

HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study.

Ait-Khaled M, Rakik A, Griffin P, Stone C, Richards N, Thomas D, Falloon J, Tisdale M; CNA2007 International Study Team. Ait-Khaled M, et al. Antivir Ther. 2003 Apr;8(2):111-20. Antivir Ther. 2003. PMID: 12741623 Clinical Trial.

7

Antiviral efficacy of abacavir in antiretroviral therapy-experienced adults harbouring HIV-1 with specific patterns of resistance to nucleoside reverse transcriptase inhibitors.

Lanier ER, Ait-Khaled M, Scott J, Stone C, Melby T, Sturge G, St Clair M, Steel H, Hetherington S, Pearce G, Spreen W, Lafon S. Lanier ER, et al. Antivir Ther. 2004 Feb;9(1):37-45. doi: 10.1177/135965350400900102. Antivir Ther. 2004. PMID: 15040535

8

Human immunodeficiency virus type 1 reverse transcriptase mutation selection during in vitro exposure to tenofovir alone or combined with abacavir or lamivudine.

Stone C, Ait-Khaled M, Craig C, Griffin P, Tisdale M. Stone C, et al. Antimicrob Agents Chemother. 2004 Apr;48(4):1413-5. doi: 10.1128/AAC.48.4.1413-1415.2004. Antimicrob Agents Chemother. 2004. PMID: 15047556 Free PMC article.

9

Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.

Cabrera C, Cozzi-Lepri A, Phillips AN, Loveday C, Kirk O, Ait-Khaled M, Reiss P, Kjaer J, Ledergerber B, Lundgren JD, Clotet B, Ruiz L; EuroSIDA Study Group. Cabrera C, et al. Antivir Ther. 2004 Oct;9(5):787-800. Antivir Ther. 2004. PMID: 15535417

10

Effect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens.

Lanier ER, Givens N, Stone C, Griffin P, Gibb D, Walker S, Tisdale M, Irlbeck D, Underwood M, St Clair M, Ait-Khaled M. Lanier ER, et al. HIV Med. 2004 Nov;5(6):394-9. doi: 10.1111/j.1468-1293.2004.00243.x. HIV Med. 2004. PMID: 15544690 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters